Wednesday, 19 June 2019

Pharma News

  • How to get your drug registered in Taiwan?

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

    The life sciences sector in Asia Pacific (APAC) provides many opportunities for organizations that are looking for growth. Regulatory approvals are, however, an ardent task for these firms ...Read more

  • Aveo, Astellas report cancer trial results

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

    Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III TIVO-1 (Tivozanib versus sorafenib in first line adv...Read more

  • Pfizer animal health firm to make pig vaccines

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Zoetis, which is the animal health business of Pfizer, received approval by Chinese Ministry of Agriculture for Rui Lan An, a specialized vaccine to help control the highly patho...Read more

  • UK, Belgium nod for Bone Therapeutics' therapy

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, received clearance from authorities in...Read more

  • Top pharma deals in the last 5 years in APAC

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    The number of mergers and acquisitions (M&A) that have been made over the past two years have almost returned to pre-downturn levels. This is in line with the recovery made by the pharm...Read more

  • Japan, Singapore to bring innovation in drug, device, technology

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

    Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Science, Technology and Research (A*Star), the National University of Singa...Read more

  • Eisai to launch in-house developed antiepileptic drug Fycompa in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2016

    Japanese pharmaceutical company Eisai Co Ltd has decided to launch its in-house-discovered antiepileptic drug (AED) Fycompa Tablets 2 mg and 4 mg (perampanel hydrate) as an adjunctive thera...Read more

  • Takeda enters into supply agreement for Omontys

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Takeda and Affymax, announced that Takeda Pharmaceuticals America (TPA) has entered into a supply agreement for sourcing and supply of Omontys (peginesatide) injection with DSI ...Read more

  • INTERPOL will help SE Asia to fight counterfeit drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Singapore: Representatives from healthcare agencies and enforcement organizations throughout the greater mekong sub-region (GMS) convened in Bangkok for the inaugural meeting of BREMERE in ...Read more

  • FDA approves Avastin for chemotherapy

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

    Singapore: The US FDA approved Genentech's Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal can...Read more

  • MHRA issues import alert to Wockhardt's India plant

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug quality issues, the company has run into trouble with UK's Medicines a...Read more

  • Cancer claimed 8.2 mn lives in 2012: UN

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million lives in 2012 and the number of cases is set to rise by 75 percent in co...Read more

  • Protagonist, Ironwood expand peptide R&D deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging Protagonist's proprietary disulfide‐rich pep...Read more

  • US Pharma: Intitate dialogue to resolve IP issues

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Corporate executives attending the day-long "US-India BioPharma and Healthcare Summit" organised by the US-India Chamber of Commerce said that they should not be considered adver...Read more

  • UK recommends BMS's Yervoy for skin cancer

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

    Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's YERVOY (ipilimumab), which is approved in the European Union for the t...Read more

  • Himalaya enters nutraceutical segment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    The Himalaya Drug Company recently launched HiOwna-Jr, a prescription-based nutritional supplement for kids, that promotes physical and mental growth, marking its entry into the $1480 milli...Read more

  • Lonza produces Bionomics' stem cell cancer drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

    Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies. Lonza will manufacture BNC1...Read more

  • China Botanic gets warning letter from NY exchange

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: China Botanic Pharmaceutical, China based biopharmaceutical company, has received a warning letter from the NYSE MKT LLC that the Company is not in compliance with Section 803(B)...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls